10 October 2009

Guidelines for use of memory-boosting drugs

Increased use of memory-boosting drugs by healthy adults prompts neurology panel to offer prescribing guidance
University of Virginia: 1 October 2009
To address a consumer trend that is gaining momentum, the Ethics, Law and Humanities Committee of the American Academy of Neurology (AAN) has released a special report, "Responding to requests from adult patients for neuroenhancements," which was published in the September 23, 2009, online issue of Neurology®, the medical journal of the AAN.

According to lead author, Dan Larriviere, MD, JD, an assistant professor of neurology at the University of Virginia School of Medicine, "A growing number of patients without illness believe they can improve their memory, cognitive focus and attention span by taking neuroenhancement drugs and are asking for prescriptions."

Originally developed to improve executive function in people with attention deficit hyperactivity disorder and Alzheimer's disease, neuroenhancement drugs - or memory-boosters - have become popular among healthy adults seeking a mental edge at work, school or in sports. The medications require a prescription and include stimulants (e.g., methylphenidates) and cholinesterase inhibitors (e.g., donepezil)…. > full press release

No comments:

Post a Comment

Alzheimer's Australia NSW

Alzheimer's Australia NSW
Alzheimer's Australia NSW

Latest headlines from Library News

Library News

Total Pageviews